language_icon
EN
HI

Asston Pharmaceuticals Share price

APL

76

3.00 (-3.80%)
Last updated on 13 May, 2026 | 15:24 IST
Today's High

76.50

Today's Low

76.00

52 Week Low

65.20

52 Week High

126.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Asston Pharmaceuticals Chart

Asston Pharmaceuticals Share Key Metrics

Volume
3000.00
Market Cap
67.25 CR
LTQ@LTP
1000@76.00
ATP
76.16
Var Margin
53.5 %
Circuit Range
63.2-94.8
Delivery %
100 %
Value
2.28 L
ASM/GSM
No
Market Lot
1000

Summary

Asston Pharmaceuticals share price stands at ₹76 at 13 May, 2026 | 15:24. The stock Asston Pharmaceuticals intraday movement has stayed between ₹76.00 and ₹76.50, while on a 52-week basis it has fluctuated from ₹65.20 to ₹126.00.
In terms of trading activity, Asston Pharmaceuticals has recorded a volume of 3000 shares. The Asston Pharmaceuticals has a market cap of ₹8512360. The stock’s Average Traded Price (ATP) stands at ₹7616, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000, 7600.
The Asston Pharmaceuticals operates within a circuit range of ₹63.2-94.8 – ₹63.2-94.8, with a Value of ₹2.28 L. The Delivery Percentage for the day is 100%. Additionally, Asston Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1000.

Asston Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

68.8

Sector P/B

3.58

Sec. Div. Yield

0.56

Asston Pharmaceuticals Resistance and Support

Pivot 79

Resistance

First Resistance

79

Second Resistance

79

Third Resistance

79

Support

First Support

79

Second Support

79

Third Support

79

Asston Pharmaceuticals Shareholding Pattern

View More
  • 2026-27
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

50.66%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

6.04%

Domestic Institutional Investors

0%

Retail

43.3%

Others

0%

Total Promoters
JUL '25
50.66%
SEP '25
50.66%

Asston Pharmaceuticals Corporate Actions

DateAgenda
2026-03-30Notice of EGM & Others
2026-02-07Raising of Funds
2026-01-05Others
2025-11-14Half Yearly Results
2025-10-16Others
2025-08-25A.G.M.

Asston Pharmaceuticals News

Asston Pharmaceuticals Ltd - 544445 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Asston Pharmaceuticals shareholders approved the appointment of M/s Panchal SK & Associates as new statutory auditors, following the resignation of the previous auditors, M/s. Doshi Doshi & Co. Additionally, three non-executive directors were regularized at the EGM.
Apr 28 2026 18:04:00

About Asston Pharmaceuticals

NSE : 0  
BSE : 544445  
ISIN : INE0SJX01015  

Our Company was originally incorporated as “Asston Pharmaceuticals Private Limited” a private limited company under Companies Act 2013 pursuant to a certificate of incorporation dated April 16 2019 issued by Registrar of Companies Mumbai Maharashtra. Thereafter our Company was converted into a public limited company and the name of our Company was changed from “Asston Pharmaceuticals Private Limited” to “Asston Pharmaceuticals Limited” vide fresh certificate of incorporation dated August 29 2024 issued by the Registrar of Companies Mumbai Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. “Asston Pharmaceuticals Private Limited” under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple productsenhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021 less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company’s achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Read More

Asston Pharmaceuticals Management

NamePosition
Ashish Narayan SakalkarManaging Director
Saili Jayaram MoreWhole Time Director & Chief Executive Officer
View More

Asston Pharmaceuticals Similar Stocks

No Data Found

Asston Pharmaceuticals FAQs

The Buying Price of Asston Pharmaceuticals share is 76 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Asston Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Asston Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Asston Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Asston Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Asston Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.8 & 3.58 with sector averages, along with growth rates and financial metrics.

The Market Cap of Asston Pharmaceuticals is 67.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Asston Pharmaceuticals share price is 126.00 & 65.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Asston Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost